SEC Form 3 · accession 0001209191-16-088123
Insight Molecular Diagnostics Inc. · IMDX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Judith Segall
Officer — Corporate Secretary
Period of report
Dec 30, 2015
Accepted (ET)
Jan 4, 2016 · 9:49 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001642380
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, no par value | holding | — | — | — | 29,657 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to Purchase Common StockF1 | $2.00 | holding | — | — | — | — | Nov 30, 2018 | Common Stock | 5,000 | — | D |
Explanation of responses
- F11/48th of the number of options vested and became exercisable at the end of each full month of employment after the date of grant on December 1, 2011.